Access to anti-retroviral drugs, male in Switzerland
Switzerland: Access to anti-retroviral drugs, male was 90.0% in 2023. ▲ Rising
Access to anti-retroviral drugs, male in Switzerland, 2000–2023
Source: UNAIDS estimates. Measured in %.
Analysis
In 2023, access to anti-retroviral drugs, male in Switzerland stood at 90.0%.
That represents a change of up 20.0% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Switzerland peaked at 91.0% in 2020 and was at its lowest, 31.0%, in 2000.
That places Switzerland 13th out of 141 countries with data for 2023, putting it in the top 10%.
The long-run direction has been consistently rising across the 24 years of available data.
Access to anti-retroviral drugs, male in Switzerland, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 31.0% | — |
| 2001 | 36.0% | +16.1% |
| 2002 | 40.0% | +11.1% |
| 2003 | 45.0% | +12.5% |
| 2004 | 49.0% | +8.9% |
| 2005 | 53.0% | +8.2% |
| 2006 | 57.0% | +7.5% |
| 2007 | 60.0% | +5.3% |
| 2008 | 63.0% | +5.0% |
| 2009 | 66.0% | +4.8% |
| 2010 | 69.0% | +4.5% |
| 2011 | 71.0% | +2.9% |
| 2012 | 74.0% | +4.2% |
| 2013 | 75.0% | +1.4% |
| 2014 | 76.0% | +1.3% |
| 2015 | 77.0% | +1.3% |
| 2016 | 82.0% | +6.5% |
| 2017 | 89.0% | +8.5% |
| 2018 | 90.0% | +1.1% |
| 2019 | 89.0% | -1.1% |
| 2020 | 91.0% | +2.2% |
| 2021 | 90.0% | -1.1% |
| 2022 | 90.0% | +0.0% |
| 2023 | 90.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 50.0% | 31.0% | 66.0% | 10 |
| 2010s | 79.2% | 69.0% | 90.0% | 10 |
| 2020s | 90.2% | 90.0% | 91.0% | 4 |
Countries ranked near Switzerland
More gender data for Switzerland
- Child population (UN estimates and projections) 1,307 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.7842 % change on previous year (2030)
- Population 7,823 (2030)
- Working-age population (UN estimates and projections) 7,823 (2030)
- Population (UN estimates and projections), annual growth rate 0.4582 % change on previous year (2030)
- Age population, age 00, female, interpolated 40,521 (2025)
- Age population, age 00, male, interpolated 42,553 (2025)
- Age population, age 01, female, interpolated 41,261 (2025)
- Age population, age 01, male, interpolated 43,323 (2025)
- Age population, age 02, female, interpolated 41,297 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Switzerland?
- Access to anti-retroviral drugs, male in Switzerland was 90.0% in 2023, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Switzerland?
- The highest recorded value was 91.0% in 2020.
- What is the lowest access to anti-retroviral drugs, male recorded in Switzerland?
- The lowest recorded value was 31.0% in 2000.
- How does Switzerland rank for access to anti-retroviral drugs, male?
- Switzerland ranks 13th out of 141 countries with data for 2023.
- Is access to anti-retroviral drugs, male rising or falling in Switzerland?
- Over the last ten years it is up 20.0%. The long-run trend across the full record is rising.
- Where does this Switzerland data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.